Susan L. Koletar

5.2k total citations
92 papers, 3.1k citations indexed

About

Susan L. Koletar is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Susan L. Koletar has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 49 papers in Emergency Medicine and 29 papers in Virology. Recurrent topics in Susan L. Koletar's work include HIV-related health complications and treatments (49 papers), HIV/AIDS Research and Interventions (31 papers) and HIV Research and Treatment (28 papers). Susan L. Koletar is often cited by papers focused on HIV-related health complications and treatments (49 papers), HIV/AIDS Research and Interventions (31 papers) and HIV Research and Treatment (28 papers). Susan L. Koletar collaborates with scholars based in United States, Puerto Rico and Philippines. Susan L. Koletar's co-authors include Kristine M. Erlandson, Ann C. Collier, Constance A. Benson, Judith S. Currier, Kunling Wu, Frank J. Palella, Katherine Tassiopoulos, Robert J. Fass, Susan E. Cohn and Babafemi Taiwo and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Susan L. Koletar

89 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan L. Koletar United States	35	1.9k	1.2k	1.2k	901	397	92	3.1k
Stefano Zona Italy	28	1.3k 0.7×	1.8k 1.5×	1.4k 1.2×	666 0.7×	314 0.8×	85	3.6k
Hernando Knobel Spain	38	2.7k 1.4×	1.5k 1.3×	1.2k 1.0×	1.5k 1.7×	201 0.5×	183	5.1k
Ferdinand W.N.M. Wit Netherlands	34	2.2k 1.2×	1.5k 1.3×	1.0k 0.9×	1.8k 2.0×	174 0.4×	109	3.6k
Babafemi Taiwo United States	31	2.1k 1.1×	744 0.6×	853 0.7×	1.4k 1.5×	150 0.4×	147	3.2k
Robert C. Kalayjian United States	30	1.5k 0.8×	1.2k 1.0×	1.1k 0.9×	937 1.0×	138 0.3×	82	3.6k
Sheldon T. Brown United States	34	1.7k 0.9×	1.1k 0.9×	2.1k 1.8×	467 0.5×	191 0.5×	113	4.0k
Andrea Calcagno Italy	27	1.6k 0.8×	773 0.6×	621 0.5×	990 1.1×	126 0.3×	229	2.8k
José L. Casado Spain	31	2.3k 1.2×	777 0.6×	1.3k 1.1×	1.3k 1.5×	115 0.3×	189	3.7k
Eugènia Negredo Spain	39	3.2k 1.7×	1.9k 1.6×	804 0.7×	2.5k 2.8×	206 0.5×	186	4.8k
Cristina Mussini Italy	29	1.4k 0.8×	549 0.5×	900 0.8×	892 1.0×	134 0.3×	159	3.1k

Countries citing papers authored by Susan L. Koletar

Since Specialization

Citations

This map shows the geographic impact of Susan L. Koletar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Koletar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Koletar more than expected).

Fields of papers citing papers by Susan L. Koletar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Koletar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Koletar. The network helps show where Susan L. Koletar may publish in the future.

Co-authorship network of co-authors of Susan L. Koletar

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Koletar. A scholar is included among the top collaborators of Susan L. Koletar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Koletar. Susan L. Koletar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiao, Xi, Liangliang Zhang, Emely A. Hoffman, et al.. (2025). Glycation metabolites predict incident age-related comorbidities and mortality in older people with HIV. GeroScience. 48(1). 379–390.

Sun, Jing, Todd T. Brown, Susan Langan, et al.. (2024). Muscle Quality and Physical Function in Men With and Without HIV. The Journals of Gerontology Series A. 79(11). 1 indexed citations

Kaur, Harpreet, Ravi Kumar Alluri, Kunling Wu, et al.. (2024). Sex-Biased Associations of Circulating Ferroptosis Inhibitors with Reduced Lipid Peroxidation and Better Neurocognitive Performance in People with HIV. Antioxidants. 13(9). 1042–1042. 1 indexed citations

Masters, Mary Clare, Jingyan Yang, Edgar T. Overton, et al.. (2023). Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes. AIDS Research and Human Retroviruses. 39(6). 302–309. 2 indexed citations

Abdo, Mona, Xingye Wu, Anjali Sharma, et al.. (2022). Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV Infection, Aging, and Immune Function Long-Term Observational Study. AIDS Research and Human Retroviruses. 38(7). 530–537. 1 indexed citations

Masters, Mary Clare, Kunling Wu, Ronald J. Ellis, et al.. (2021). Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases. 73(4). 680–688. 11 indexed citations

Bowman, Emily, Cheryl Cameron, Brian Richardson, et al.. (2020). Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms. PLoS Pathogens. 16(10). e1008869–e1008869. 21 indexed citations

Tibuakuu, Martin, Di Zhao, Todd T. Brown, et al.. (2018). Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS). Journal of cardiovascular computed tomography. 12(2). 131–138. 7 indexed citations

Erlandson, Kristine M., Kunling Wu, Susan L. Koletar, et al.. (2017). Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy. The Journal of Infectious Diseases. 215(6). 933–937. 63 indexed citations

10.

Erlandson, Kristine M., Douglas Kitch, C. William Wester, et al.. (2017). The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 65(12). 2042–2049. 13 indexed citations

11.

Price, Jennifer C., Eric C. Seaberg, John Phair, et al.. (2016). Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(3). 319–323. 4 indexed citations

12.

Wang, Daqing, et al.. (2012). Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. BMC Medical Genomics. 5(1). 32–32. 34 indexed citations

13.

Krishnan, Supriya, Jeffrey T. Schouten, Denise L. Jacobson, et al.. (2011). Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis. Oncology. 80(1-2). 42–49. 32 indexed citations

14.

Chow, Dominic C., Huichao Chen, Marshall J. Glesby, et al.. (2009). Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS. 23(16). 2133–2141. 30 indexed citations

15.

Sax, Paul E., Camlin Tierney, Ann C. Collier, et al.. (2009). Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy. New England Journal of Medicine. 361(23). 2230–2240. 215 indexed citations

16.

Gupta, Samir K., Susan L. Rosenkranz, Yoninah Cramer, et al.. (2008). The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. AIDS. 22(15). 1919–1927. 26 indexed citations

17.

MacGregor, Rob Roy, Richard Hafner, Julia Wu, et al.. (2005). Clinical, Microbiological, and Immunological Characteristics in HIV-Infected Subjects at Risk for Disseminated Mycobacterium avium Complex Disease: An AACTG Study. AIDS Research and Human Retroviruses. 21(8). 689–695. 8 indexed citations

18.

Wohl, David A., Christopher D. Pilcher, Scott B. Evans, et al.. (2004). Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3). 274–278. 14 indexed citations

19.

Allen, Carl M., et al.. (2002). Prevalence of fluconazole‐resistant strains ofCandida albicansin otherwise healthy outpatients. Journal of Oral Pathology and Medicine. 31(2). 99–105. 18 indexed citations

20.

Cahill, Kenneth V., et al.. (1994). Intraorbital Injection of Amphotericin B for Palliative Treatment of Aspergillus Orbital Abscess. Ophthalmic Plastic and Reconstructive Surgery. 10(4). 276–277. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact